Fil LTD Seagen Inc. Transaction History

Fil LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$127.59 - $203.08 $29 Million - $46.2 Million	-227,574 Reduced 72.18%	87,728 $17.8 Million
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $37 Million - $43.9 Million	315,302 New	315,302 $40.5 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $25.1 Million - $41.3 Million	230,505 New	230,505 $40.8 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $40,428 - $53,353	-338 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $364,123 - $487,456	-2,554 Reduced 88.31%	338 $52,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $4.51 Million - $5.38 Million	-31,679 Reduced 91.63%	2,892 $491,000
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $207,482 - $247,449	1,536 Added 4.65%	34,571 $5.46 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $4.53 Million - $6.28 Million	32,913 Added 26977.87%	33,035 $4.59 Million
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $20,084 - $25,855	122 New	122 $21,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.